SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-16-135457
Filing Date
2016-11-21
Accepted
2016-11-21 06:04:23
Documents
46
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A v453497_10qa.htm 10-Q/A 249303
2 EXHIBIT 31.1 v453497_ex31-1.htm EX-31.1 9597
3 EXHIBIT 31.2 v453497_ex31-2.htm EX-31.2 9682
4 EXHIBIT 32.1 v453497_ex32-1.htm EX-32.1 4359
5 EXHIBIT 32.2 v453497_ex32-2.htm EX-32.2 4116
  Complete submission text file 0001144204-16-135457.txt   2682870

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mbrx-20160630.xml EX-101.INS 481179
7 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20160630.xsd EX-101.SCH 36873
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20160630_cal.xml EX-101.CAL 17697
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20160630_def.xml EX-101.DEF 197062
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20160630_lab.xml EX-101.LAB 243614
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20160630_pre.xml EX-101.PRE 223624
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37758 | Film No.: 162008987
SIC: 2834 Pharmaceutical Preparations